UTAH MEDICAL PRODUCTS INC
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $8.5M | $12.1M | $11.8M | $11.4M | $11.4M | $10.2M | $7.4M | $6.0M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $660.0K | $610.0K | $619.0K | $637.0K | $611.0K | $653.0K | $707.0K | $563.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $129.0K | $92.0K | $87.0K | $74.0K | $28.0K | $70.0K | $95.0K | $83.0K |
| Net Cash from Operating Activities | $16.9M | $14.5M | $13.8M | $15.4M | $12.3M | $13.6M | $11.4M | $7.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.6M | $3.3M | $176.0K | $1.1M | $339.0K | $254.0K | $247.0K | $1.5M |
| Business Acquisitions | — | — | — | — | $0 | $0 | $41.1M | — |
| Net Cash from Investing Activities | $-1.6M | $-3.3M | $-246.0K | $-1.1M | $-344.0K | $-208.0K | $-26.7M | $2.7M |
| Financing Activities | ||||||||
| Dividends Paid | $3.0M | $3.9M | $3.8M | $3.8M | $3.7M | $3.6M | $3.4M | $6.0M |
| Stock Repurchases | $0 | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-2.7M | $-6.3M | $-8.9M | $-8.3M | $-6.6M | $-11.2M | $18.1M | $-6.4M |
| Net Change in Cash | $13.6M | $3.0M | $4.0M | $4.9M | $5.5M | $2.3M | $2.7M | $3.4M |
| Free Cash Flow | $15.3M | $11.2M | $13.6M | $14.3M | $12.0M | $13.3M | $11.1M | $5.6M |